Pfizer obtains FDA OK for first vaccine for pregnant women to prevent RSV in infantsAbrysvo is the first vaccine approved for use in pregnant women to prevent lower respiratory tract disease and severe LRTD. Gilead gets FDA nod for new indication for VekluryVeklury is the only approved COVID-19 antiviral treatment across all stages of liver disease. CVS Health launches Cordavis As its first product, Cordavis has contracted with Sandoz to commercialize and bring to market Hyrimoz, a biosimilar for Humira. FDA OKs new indication for Eli Lilly’s Verzenio High-risk patients eligible for Verzenio can now be identified solely based on nodal status, tumor size and tumor grade, regardless of Ki-67 score. Rising Pharmaceuticals launches Edetate calcium disodium injection Edetate calcium disodium injection is prescribed to reduce blood lead levels in both pediatric and adult populations. Teva to pay $225M, Glenmark to pay $30M to settle price fixing charges Generic drug makers Teva and Glenmark have agreed to divest their generic Pravachol business. CVS Pharmacy, Walgreens to acquire prescription files from SEG's pharmacies The move follows Aldi's definitive agreement to acquire Winn-Dixie and Harveys Supermarket as part of a larger divestiture of Southeastern Grocers to various entities. Organon achieves national formulary access for Hadlima Hadlima is a tumor necrosis factor blocker indicated for patients with a variety of conditions. Johnson & Johnson announces final results of exchange offer, finalizes separation of Kenvue Johnson & Johnson has completed its Kenvue separation. GRx+Bosims 2023 to feature FDA Commissioner Robert Califf FDA Commissioner Robert Califf will be the keynote FDA speaker during a “Fireside Chat” at GRx+Bosims 2023, which will be held Oct. 2-4. First Previous 108 109 110 111 112 Next Last
